As a strong advocate for patients throughout his career, Dr. Mills’ mission at CIRM is to speed up the development of new treatments and cures by finding real-time solutions for the regulatory, clinical, manufacturing and business problems that often slow down novel therapies. Previously, Mills served as the CEO of Osiris Therapeutics. Under his leadership, Osiris developed and commercialized five cell therapy products responsible for more than $1 billion in cumulative sales. Prior to joining Osiris, Mills was a Co-founder and VP of Regeneration Technologies. Mills invented the company’s core technology, BioCleanse®, the first system accepted by the Food and Drug Administration (FDA) for the sterilization of human tissue for transplantation. Mills currently serves as the Chairman of Tissue Banks International. He also serves on the Board of the Alliance for Regenerative Medicine and the Wake Forest Institute of Regenerative Medicine.